25 XP   0   0   10

Maravai Lifesciences Holdings Inc
Buy, Hold or Sell?

Let's analyse Maravai together

PenkeI guess you are interested in Maravai Lifesciences Holdings Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Maravai Lifesciences Holdings Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Maravai Lifesciences Holdings Inc

I send you an email if I find something interesting about Maravai Lifesciences Holdings Inc.

Quick analysis of Maravai (30 sec.)










What can you expect buying and holding a share of Maravai? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
11.8%

What is your share worth?

Current worth
$5.97
Expected worth in 1 year
$5.10
How sure are you?
47.1%

+ What do you gain per year?

Total Gains per Share
$-0.87
Return On Investment
-11.1%

For what price can you sell your share?

Current Price per Share
$7.85
Expected price per share
$7.18 - $8.87
How sure are you?
50%

1. Valuation of Maravai (5 min.)




Live pricePrice per Share (EOD)

$7.85

Intrinsic Value Per Share

$-14.23 - $-17.95

Total Value Per Share

$-8.26 - $-11.98

2. Growth of Maravai (5 min.)




Is Maravai growing?

Current yearPrevious yearGrowGrow %
How rich?$789.8m$793.7m$76.3m8.8%

How much money is Maravai making?

Current yearPrevious yearGrowGrow %
Making money-$30m$122.6m-$152.7m-507.8%
Net Profit Margin-40.9%54.9%--

How much money comes from the company's main activities?

3. Financial Health of Maravai (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#69 / 1007

Most Revenue
#120 / 1007

Most Profit
#790 / 1007

Most Efficient
#521 / 1007

What can you expect buying and holding a share of Maravai? (5 min.)

Welcome investor! Maravai's management wants to use your money to grow the business. In return you get a share of Maravai.

What can you expect buying and holding a share of Maravai?

First you should know what it really means to hold a share of Maravai. And how you can make/lose money.

Speculation

The Price per Share of Maravai is $7.85. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Maravai.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Maravai, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $5.97. Based on the TTM, the Book Value Change Per Share is $-0.22 per quarter. Based on the YOY, the Book Value Change Per Share is $0.68 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Maravai.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.80-10.2%-0.22-2.9%0.293.7%0.121.5%0.121.5%
Usd Book Value Change Per Share-0.77-9.9%-0.22-2.8%0.688.7%0.354.5%0.354.5%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.070.9%0.070.9%
Usd Total Gains Per Share-0.77-9.9%-0.22-2.8%0.688.7%0.425.3%0.425.3%
Usd Price Per Share6.55-10.75-25.88-20.17-20.17-
Price to Earnings Ratio-2.04--1,758.13-22.67--396.65--396.65-
Price-to-Total Gains Ratio-8.46--309.38-18.91--82.02--82.02-
Price to Book Ratio1.10-1.62-7.31-8.05-8.05-
Price-to-Total Gains Ratio-8.46--309.38-18.91--82.02--82.02-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share7.85
Number of shares127
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.07
Usd Book Value Change Per Share-0.220.35
Usd Total Gains Per Share-0.220.42
Gains per Quarter (127 shares)-27.6053.28
Gains per Year (127 shares)-110.41213.13
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-111-12035178203
21-221-23069357416
31-332-340104535629
41-443-450139714842
52-554-5601748921055
62-664-67020810701268
72-775-78024312491481
83-886-89027814271694
93-997-100031316061907
103-1107-111034717842120

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%8.04.00.066.7%12.05.00.070.6%12.05.00.070.6%12.05.00.070.6%
Book Value Change Per Share0.04.00.00.0%6.06.00.050.0%8.07.02.047.1%8.07.02.047.1%8.07.02.047.1%
Dividend per Share1.00.03.025.0%2.00.010.016.7%2.00.015.011.8%2.00.015.011.8%2.00.015.011.8%
Total Gains per Share0.04.00.00.0%6.06.00.050.0%8.07.02.047.1%8.07.02.047.1%8.07.02.047.1%

Fundamentals of Maravai

About Maravai Lifesciences Holdings Inc

Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases worldwide. The company's products address the key phases of biopharmaceutical development and include nucleic acids for diagnostic and therapeutic applications, antibody-based products to detect impurities during the production of biopharmaceutical products, and products to detect the expression of proteins in tissues of various species. It operates in two segments, Nucleic Acid Production and Biologics Safety Testing. The Nucleic Acid Production segment manufactures and sells products for use in the fields of gene therapy, vaccines, nucleoside chemistry, oligonucleotide therapy, and molecular diagnostics, including reagents used in the chemical synthesis, modification, labelling, and purification of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). This segment also offers messenger RNA, oligonucleotides, and oligonucleotide building blocks, as well as custom enzyme development and manufacturing and CleanCap capping technology. The Biologics Safety Testing segment sells analytical products for use in biologic manufacturing process development, including custom product-specific development antibody, and assay development services. This segment also provides HCP ELISA kits, other bioprocess impurity and contaminant ELISA kits, ancillary reagents, viral clearance prediction kits, and custom services. The company serves biopharmaceutical companies, and other biopharmaceutical and life sciences research companies; and academic research institutions and in vitro diagnostics companies. The company was incorporated in 2020 and is headquartered in San Diego, California.

Fundamental data was last updated by Penke on 2024-04-11 15:11:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Maravai Lifesciences Holdings Inc.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Maravai earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Maravai to the Biotechnology industry mean.
  • A Net Profit Margin of -142.9% means that $-1.43 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Maravai Lifesciences Holdings Inc:

  • The MRQ is -142.9%. The company is making a huge loss. -2
  • The TTM is -40.9%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-142.9%TTM-40.9%-102.0%
TTM-40.9%YOY54.9%-95.8%
TTM-40.9%5Y14.5%-55.4%
5Y14.5%10Y14.5%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-142.9%-207.2%+64.3%
TTM-40.9%-216.8%+175.9%
YOY54.9%-282.4%+337.3%
5Y14.5%-434.0%+448.5%
10Y14.5%-584.8%+599.3%
1.1.2. Return on Assets

Shows how efficient Maravai is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Maravai to the Biotechnology industry mean.
  • -7.1% Return on Assets means that Maravai generated $-0.07 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Maravai Lifesciences Holdings Inc:

  • The MRQ is -7.1%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -1.9%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-7.1%TTM-1.9%-5.2%
TTM-1.9%YOY5.7%-7.6%
TTM-1.9%5Y2.2%-4.1%
5Y2.2%10Y2.2%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-7.1%-13.2%+6.1%
TTM-1.9%-12.7%+10.8%
YOY5.7%-11.5%+17.2%
5Y2.2%-13.8%+16.0%
10Y2.2%-15.5%+17.7%
1.1.3. Return on Equity

Shows how efficient Maravai is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Maravai to the Biotechnology industry mean.
  • -25.4% Return on Equity means Maravai generated $-0.25 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Maravai Lifesciences Holdings Inc:

  • The MRQ is -25.4%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -7.0%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-25.4%TTM-7.0%-18.4%
TTM-7.0%YOY27.1%-34.2%
TTM-7.0%5Y11.9%-19.0%
5Y11.9%10Y11.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-25.4%-16.7%-8.7%
TTM-7.0%-15.9%+8.9%
YOY27.1%-14.7%+41.8%
5Y11.9%-19.2%+31.1%
10Y11.9%-20.0%+31.9%

1.2. Operating Efficiency of Maravai Lifesciences Holdings Inc.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Maravai is operating .

  • Measures how much profit Maravai makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Maravai to the Biotechnology industry mean.
  • An Operating Margin of 0.3% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Maravai Lifesciences Holdings Inc:

  • The MRQ is 0.3%. The company is operating inefficient. -1
  • The TTM is -10.6%. The company is operating very inefficient. -2
Trends
Current periodCompared to+/- 
MRQ0.3%TTM-10.6%+10.9%
TTM-10.6%YOY64.4%-74.9%
TTM-10.6%5Y35.1%-45.7%
5Y35.1%10Y35.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.3%-298.0%+298.3%
TTM-10.6%-238.5%+227.9%
YOY64.4%-291.9%+356.3%
5Y35.1%-485.6%+520.7%
10Y35.1%-610.8%+645.9%
1.2.2. Operating Ratio

Measures how efficient Maravai is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 1.00 means that the operating costs are $1.00 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Maravai Lifesciences Holdings Inc:

  • The MRQ is 0.997. The company is less efficient in keeping operating costs low.
  • The TTM is 1.091. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ0.997TTM1.091-0.093
TTM1.091YOY0.364+0.726
TTM1.0915Y0.632+0.459
5Y0.63210Y0.6320.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.9973.235-2.238
TTM1.0913.310-2.219
YOY0.3643.791-3.427
5Y0.6325.675-5.043
10Y0.6327.558-6.926

1.3. Liquidity of Maravai Lifesciences Holdings Inc.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Maravai is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 8.00 means the company has $8.00 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Maravai Lifesciences Holdings Inc:

  • The MRQ is 8.002. The company is very able to pay all its short-term debts. +2
  • The TTM is 8.105. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ8.002TTM8.105-0.104
TTM8.105YOY7.203+0.902
TTM8.1055Y5.102+3.004
5Y5.10210Y5.1020.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ8.0023.877+4.125
TTM8.1054.178+3.927
YOY7.2035.343+1.860
5Y5.1026.135-1.033
10Y5.1026.468-1.366
1.3.2. Quick Ratio

Measures if Maravai is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Maravai to the Biotechnology industry mean.
  • A Quick Ratio of 7.21 means the company can pay off $7.21 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Maravai Lifesciences Holdings Inc:

  • The MRQ is 7.210. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 7.283. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ7.210TTM7.283-0.073
TTM7.283YOY6.490+0.793
TTM7.2835Y4.508+2.775
5Y4.50810Y4.5080.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ7.2103.514+3.696
TTM7.2833.998+3.285
YOY6.4905.380+1.110
5Y4.5086.135-1.627
10Y4.5086.434-1.926

1.4. Solvency of Maravai Lifesciences Holdings Inc.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Maravai assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Maravai to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.47 means that Maravai assets are financed with 46.9% credit (debt) and the remaining percentage (100% - 46.9%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Maravai Lifesciences Holdings Inc:

  • The MRQ is 0.469. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.573. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.469TTM0.573-0.104
TTM0.573YOY0.638-0.066
TTM0.5735Y0.716-0.143
5Y0.71610Y0.7160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4690.339+0.130
TTM0.5730.336+0.237
YOY0.6380.271+0.367
5Y0.7160.368+0.348
10Y0.7160.388+0.328
1.4.2. Debt to Equity Ratio

Measures if Maravai is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Maravai to the Biotechnology industry mean.
  • A Debt to Equity ratio of 167.4% means that company has $1.67 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Maravai Lifesciences Holdings Inc:

  • The MRQ is 1.674. The company is just able to pay all its debts with equity.
  • The TTM is 2.415. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ1.674TTM2.415-0.741
TTM2.415YOY3.003-0.588
TTM2.4155Y4.066-1.651
5Y4.06610Y4.0660.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.6740.388+1.286
TTM2.4150.403+2.012
YOY3.0030.340+2.663
5Y4.0660.430+3.636
10Y4.0660.463+3.603

2. Market Valuation of Maravai Lifesciences Holdings Inc

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Maravai generates.

  • Above 15 is considered overpriced but always compare Maravai to the Biotechnology industry mean.
  • A PE ratio of -2.04 means the investor is paying $-2.04 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Maravai Lifesciences Holdings Inc:

  • The EOD is -2.450. Based on the earnings, the company is expensive. -2
  • The MRQ is -2.045. Based on the earnings, the company is expensive. -2
  • The TTM is -1,758.133. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-2.450MRQ-2.045-0.406
MRQ-2.045TTM-1,758.133+1,756.088
TTM-1,758.133YOY22.673-1,780.806
TTM-1,758.1335Y-396.650-1,361.483
5Y-396.65010Y-396.6500.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-2.450-2.281-0.169
MRQ-2.045-2.599+0.554
TTM-1,758.133-2.674-1,755.459
YOY22.673-4.133+26.806
5Y-396.650-6.258-390.392
10Y-396.650-6.270-390.380
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Maravai Lifesciences Holdings Inc:

  • The EOD is -28.821. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -24.048. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -71.821. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-28.821MRQ-24.048-4.773
MRQ-24.048TTM-71.821+47.772
TTM-71.821YOY9.624-81.445
TTM-71.8215Y-8.050-63.771
5Y-8.05010Y-8.0500.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-28.821-2.903-25.918
MRQ-24.048-3.323-20.725
TTM-71.821-3.552-68.269
YOY9.624-5.592+15.216
5Y-8.050-8.378+0.328
10Y-8.050-8.875+0.825
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Maravai is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 1.10 means the investor is paying $1.10 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Maravai Lifesciences Holdings Inc:

  • The EOD is 1.315. Based on the equity, the company is underpriced. +1
  • The MRQ is 1.097. Based on the equity, the company is underpriced. +1
  • The TTM is 1.618. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD1.315MRQ1.097+0.218
MRQ1.097TTM1.618-0.520
TTM1.618YOY7.310-5.693
TTM1.6185Y8.049-6.431
5Y8.04910Y8.0490.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD1.3151.911-0.596
MRQ1.0972.116-1.019
TTM1.6182.097-0.479
YOY7.3102.885+4.425
5Y8.0493.556+4.493
10Y8.0493.959+4.090
2. Total Gains per Share

3. Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Maravai Lifesciences Holdings Inc.

3.1. Institutions holding Maravai Lifesciences Holdings Inc

Institutions are holding 102.61% of the shares of Maravai Lifesciences Holdings Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2023-12-31GTCR LLC16.38718.61872168103300
2023-12-3112 West Capital Management LP8.76986.76111602988513987779.5264
2023-12-31Vanguard Group Inc7.56120.001410003894-213388-2.0885
2023-12-31BlackRock Inc4.8990.001164816685543609.3526
2023-12-31Massachusetts Financial Services Company4.5460.01276014575-2138905-26.233
2023-12-31Millennium Management LLC4.37380.01645786849152465035.7714
2023-12-31Mackenzie Investments3.9070.051151691762383354.8336
2023-09-30BRAIDWELL LP3.00431.256139748572170157120.2503
2023-12-31AQR Capital Management LLC2.64850.043235041111755108100.3491
2023-12-31Pacer Advisors, INC.2.23360.0548295523081095737.8197
2023-12-31Renaissance Technologies Corp2.18110.029328856892260008.4972
2023-12-31Morgan Stanley - Brokerage Accounts2.16860.001728691481442909101.1688
2023-12-31Marshall Wace Asset Management Ltd2.00090.029426473331889796249.4658
2023-09-30Alyeska Investment Group, L.P.1.80320.1622385747-90000-3.6353
2023-12-31Ameriprise Financial Inc1.64890.00432181617-4771-0.2182
2023-09-30Holocene Advisors, LP1.62630.0942215165621516560
2023-12-31Glenmede Trust Co NA1.57430.0708208292897437487.8959
2023-12-31State Street Corporation1.52330.0006201536820786911.5004
2023-12-31Geode Capital Management, LLC1.33630.00121768011631093.7016
2023-09-30Citadel Advisors Llc1.33190.00381762130174577410673.5999
Total 75.525117.213899924008+18447867+18.5%

3.2. Funds holding Maravai Lifesciences Holdings Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2024-01-31Canada Life US Small-Mid Cap Growth A2.70580.9428357996000
2024-02-29Vanguard Total Stock Mkt Idx Inv2.48740.0016329091000
2024-02-29Vanguard Small Cap Index2.06020.0152725749252220.934
2024-03-31First Trust Health Care AlphaDEX® ETF1.7331.498229292500
2024-02-29Columbia Acorn Inst1.71920.6088227456800
2023-12-31Glenmede Small Cap Equity1.441.1343190515389409888.4322
2023-12-31Glenmede Small Cap Equity Adv1.441.1343190515389409888.4322
2023-12-31MFS Mid Cap Value Equity1.25760.06731663874-28995-1.7128
2024-02-29MFS Mid Cap Value A1.24270.07711644144-19730-1.1858
2024-02-29Vanguard Institutional Extnd Mkt Idx Tr1.24170.0124164283911070.0674
2024-02-29Vanguard Small Cap Growth Index Inv1.15630.03391529900254531.6919
2024-02-29MFS New Discovery Value I0.88560.26411171669-8395-0.7114
2023-12-31Baron Discovery Strategy0.85380.51811129676615081119.5272
2023-12-31Baron Discovery Institutional0.85380.51771129676615081119.5272
2023-12-31MFS Research Equity - Industry Neutral0.75950.10231004919-844162-45.6531
2024-02-29MFS Core Equity A0.74740.1136988903-7583-0.761
2024-03-28iShares Biotechnology ETF0.60460.0909799894-8921-1.103
2024-02-29Xtrackers S&P 500 Swap ETF 1C0.55930.063274001700
2024-02-29MFS New Discovery I0.53050.220470182500
2024-02-29State St Russell Sm/Mid Cp® Indx NL Cl C0.52580.0129695609273004.0849
Total 24.80427.428732817363+2179654+6.6%

4. Summary

4.1. Key Performance Indicators

The key performance indicators of Maravai Lifesciences Holdings Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.774-0.218-72%0.680-214%0.351-320%0.351-320%
Book Value Per Share--5.9706.576-9%4.699+27%3.479+72%3.479+72%
Current Ratio--8.0028.105-1%7.203+11%5.102+57%5.102+57%
Debt To Asset Ratio--0.4690.573-18%0.638-27%0.716-34%0.716-34%
Debt To Equity Ratio--1.6742.415-31%3.003-44%4.066-59%4.066-59%
Dividend Per Share---0.001-100%-0%0.068-100%0.068-100%
Eps---0.801-0.225-72%0.290-376%0.121-762%0.121-762%
Free Cash Flow Per Share---0.0680.115-159%0.687-110%0.382-118%0.382-118%
Free Cash Flow To Equity Per Share---0.065-0.001-99%0.409-116%0.253-125%0.253-125%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---17.954--------
Intrinsic Value_10Y_min---14.232--------
Intrinsic Value_1Y_max--1.308--------
Intrinsic Value_1Y_min--1.287--------
Intrinsic Value_3Y_max--1.562--------
Intrinsic Value_3Y_min--1.539--------
Intrinsic Value_5Y_max---1.038--------
Intrinsic Value_5Y_min---0.760--------
Market Cap1038602100.000+17%866604300.0001421958735.000-39%5382462385.000-84%3492530508.235-75%3492530508.235-75%
Net Profit Margin---1.429-0.409-71%0.549-360%0.145-1087%0.145-1087%
Operating Margin--0.003-0.106+3786%0.644-100%0.351-99%0.351-99%
Operating Ratio--0.9971.091-9%0.364+174%0.632+58%0.632+58%
Pb Ratio1.315+17%1.0971.618-32%7.310-85%8.049-86%8.049-86%
Pe Ratio-2.450-20%-2.045-1758.133+85886%22.673-109%-396.650+19299%-396.650+19299%
Price Per Share7.850+17%6.55010.748-39%25.880-75%20.171-68%20.171-68%
Price To Free Cash Flow Ratio-28.821-20%-24.048-71.821+199%9.624-350%-8.050-67%-8.050-67%
Price To Total Gains Ratio-10.143-20%-8.463-309.381+3556%18.908-145%-82.017+869%-82.017+869%
Quick Ratio--7.2107.283-1%6.490+11%4.508+60%4.508+60%
Return On Assets---0.071-0.019-73%0.057-226%0.022-431%0.022-431%
Return On Equity---0.254-0.070-72%0.271-194%0.119-313%0.119-313%
Total Gains Per Share---0.774-0.217-72%0.680-214%0.420-284%0.420-284%
Usd Book Value--789884000.000870110250.000-9%793751500.0000%513727882.353+54%513727882.353+54%
Usd Book Value Change Per Share---0.774-0.218-72%0.680-214%0.351-320%0.351-320%
Usd Book Value Per Share--5.9706.576-9%4.699+27%3.479+72%3.479+72%
Usd Dividend Per Share---0.001-100%-0%0.068-100%0.068-100%
Usd Eps---0.801-0.225-72%0.290-376%0.121-762%0.121-762%
Usd Free Cash Flow---9009000.00015167750.000-159%129721750.000-107%62620117.647-114%62620117.647-114%
Usd Free Cash Flow Per Share---0.0680.115-159%0.687-110%0.382-118%0.382-118%
Usd Free Cash Flow To Equity Per Share---0.065-0.001-99%0.409-116%0.253-125%0.253-125%
Usd Market Cap1038602100.000+17%866604300.0001421958735.000-39%5382462385.000-84%3492530508.235-75%3492530508.235-75%
Usd Price Per Share7.850+17%6.55010.748-39%25.880-75%20.171-68%20.171-68%
Usd Profit---105959000.000-30077500.000-72%122665750.000-186%37361352.941-384%37361352.941-384%
Usd Revenue--74141000.00072236250.000+3%220750250.000-66%134779058.824-45%134779058.824-45%
Usd Total Gains Per Share---0.774-0.217-72%0.680-214%0.420-284%0.420-284%
 EOD+5 -3MRQTTM+8 -27YOY+10 -235Y+11 -2410Y+11 -24

4.2. Fundamental Score

Let's check the fundamental score of Maravai Lifesciences Holdings Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-2.450
Price to Book Ratio (EOD)Between0-11.315
Net Profit Margin (MRQ)Greater than0-1.429
Operating Margin (MRQ)Greater than00.003
Quick Ratio (MRQ)Greater than17.210
Current Ratio (MRQ)Greater than18.002
Debt to Asset Ratio (MRQ)Less than10.469
Debt to Equity Ratio (MRQ)Less than11.674
Return on Equity (MRQ)Greater than0.15-0.254
Return on Assets (MRQ)Greater than0.05-0.071
Total4/10 (40.0%)

4.3. Technical Score

Let's check the technical score of Maravai Lifesciences Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.799
Ma 20Greater thanMa 508.017
Ma 50Greater thanMa 1007.767
Ma 100Greater thanMa 2006.907
OpenGreater thanClose7.760
Total2/5 (40.0%)



Reversals in quarterly reports

I have detected a reversal (positive to negative, negative to positive) in the following values of the quarterly reports.

 2022-12-312023-03-312023-06-302023-09-302023-12-31
Long-term Assets Other  40,33176,712117,043-103,30313,740-4,2889,452-221,122-211,670



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in USD. All numbers in thousands.

Summary
Total Assets1,487,450
Total Liabilities697,566
Total Stockholder Equity416,753
 As reported
Total Liabilities 697,566
Total Stockholder Equity+ 416,753
Total Assets = 1,487,450

Assets

Total Assets1,487,450
Total Current Assets699,912
Long-term Assets787,538
Total Current Assets
Cash And Cash Equivalents 574,962
Net Receivables 55,723
Inventory 51,397
Other Current Assets 17,830
Total Current Assets  (as reported)699,912
Total Current Assets  (calculated)699,912
+/-0
Long-term Assets
Property Plant Equipment 222,646
Goodwill 326,029
Intangible Assets 220,987
Long-term Assets  (as reported)787,538
Long-term Assets  (calculated)769,662
+/- 17,876

Liabilities & Shareholders' Equity

Total Current Liabilities87,468
Long-term Liabilities610,098
Total Stockholder Equity416,753
Total Current Liabilities
Short-term Debt 12,853
Short Long Term Debt 5,440
Accounts payable 10,729
Other Current Liabilities 60,526
Total Current Liabilities  (as reported)87,468
Total Current Liabilities  (calculated)89,548
+/- 2,080
Long-term Liabilities
Long term Debt 518,707
Capital Lease Obligations 86,820
Long-term Liabilities Other 2,394
Long-term Liabilities  (as reported)610,098
Long-term Liabilities  (calculated)607,921
+/- 2,177
Total Stockholder Equity
Common Stock2,513
Retained Earnings 285,737
Other Stockholders Equity 128,503
Total Stockholder Equity (as reported)416,753
Total Stockholder Equity (calculated)416,753
+/-0
Other
Capital Stock2,513
Cash and Short Term Investments 574,962
Common Stock Shares Outstanding 132,140
Current Deferred Revenue3,360
Liabilities and Stockholders Equity 1,487,450
Net Debt 36,005
Net Invested Capital 940,900
Net Working Capital 612,444
Property Plant and Equipment Gross 254,860
Short Long Term Debt Total 610,967



Balance Sheet

Currency in USD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-31
> Total Assets 
577,796
0
0
649,544
1,270,691
1,351,768
1,601,247
1,894,683
1,918,276
2,043,230
2,171,799
2,248,899
2,282,315
2,315,388
2,264,437
2,267,553
1,487,450
1,487,4502,267,5532,264,4372,315,3882,282,3152,248,8992,171,7992,043,2301,918,2761,894,6831,601,2471,351,7681,270,691649,54400577,796
   > Total Current Assets 
60,552
24,700
0
145,553
331,598
425,543
644,491
687,478
740,039
619,135
759,382
835,526
847,902
765,513
699,312
700,865
699,912
699,912700,865699,312765,513847,902835,526759,382619,135740,039687,478644,491425,543331,598145,553024,70060,552
       Cash And Cash Equivalents 
24,700
-24,700
0
36,314
236,184
247,675
374,710
547,898
551,272
431,469
550,676
617,446
632,138
628,273
580,176
579,605
574,962
574,962579,605580,176628,273632,138617,446550,676431,469551,272547,898374,710247,675236,18436,3140-24,70024,700
       Short-term Investments 
0
49,400
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000049,4000
       Net Receivables 
18,030
0
0
73,301
51,018
121,821
83,534
65,939
117,512
120,355
128,929
132,224
146,814
56,889
49,219
49,202
55,723
55,72349,20249,21956,889146,814132,224128,929120,355117,51265,93983,534121,82151,01873,3010018,030
       Inventory 
14,202
0
0
26,586
33,301
47,129
47,781
56,246
51,557
51,409
60,113
62,424
43,152
54,819
47,402
49,142
51,397
51,39749,14247,40254,81943,15262,42460,11351,40951,55756,24647,78147,12933,30126,5860014,202
       Other Current Assets 
3,620
0
0
9,352
11,095
8,918
138,466
17,395
19,698
15,902
19,664
23,432
25,798
25,532
22,515
22,916
17,830
17,83022,91622,51525,53225,79823,43219,66415,90219,69817,395138,4668,91811,0959,352003,620
   > Long-term Assets 
517,244
0
0
503,992
939,093
926,225
956,756
1,207,205
1,178,237
1,424,095
1,412,417
1,413,373
1,434,413
1,549,875
1,565,125
1,566,688
787,538
787,5381,566,6881,565,1251,549,8751,434,4131,413,3731,412,4171,424,0951,178,2371,207,205956,756926,225939,093503,99200517,244
       Property Plant Equipment 
94,311
0
0
96,089
101,305
105,133
104,751
108,322
46,332
47,702
103,748
113,269
116,590
87,721
206,633
216,424
222,646
222,646216,424206,63387,721116,590113,269103,74847,70246,332108,322104,751105,133101,30596,0890094,311
       Goodwill 
224,275
0
0
224,275
224,275
224,275
152,766
152,766
152,766
283,535
283,535
283,535
283,668
326,569
326,459
326,029
326,029
326,029326,029326,459326,569283,668283,535283,535283,535152,766152,766152,766224,275224,275224,27500224,275
       Intangible Assets 
197,853
0
0
182,821
177,656
172,616
125,116
121,225
117,571
235,405
229,153
222,899
216,663
241,578
234,726
227,856
220,987
220,987227,856234,726241,578216,663222,899229,153235,405117,571121,225125,116172,616177,656182,82100197,853
       Other Assets 
805
0
0
-1
0
424,201
574,123
824,892
812,473
853,738
800,138
794,031
806,130
0
783,307
0
0
00783,3070806,130794,031800,138853,738812,473824,892574,123424,2010-100805
> Total Liabilities 
433,169
0
0
702,118
1,115,945
1,142,012
1,268,106
1,441,067
1,372,915
1,388,928
1,398,007
1,407,230
1,377,072
1,414,750
1,366,799
1,375,272
697,566
697,5661,375,2721,366,7991,414,7501,377,0721,407,2301,398,0071,388,9281,372,9151,441,0671,268,1061,142,0121,115,945702,11800433,169
   > Total Current Liabilities 
29,562
0
0
280,451
130,778
165,252
164,773
114,352
93,777
86,675
112,530
115,655
110,144
124,896
74,919
78,253
87,468
87,46878,25374,919124,896110,144115,655112,53086,67593,777114,352164,773165,252130,778280,4510029,562
       Short-term Debt 
2,500
0
0
2,500
6,000
6,000
6,000
6,000
9,722
5,440
9,751
11,273
11,709
12,486
12,918
13,129
12,853
12,85313,12912,91812,48611,70911,2739,7515,4409,7226,0006,0006,0006,0002,500002,500
       Short Long Term Debt 
2,500
0
0
2,500
6,000
6,000
6,000
6,000
6,000
5,440
5,440
5,440
5,440
5,440
5,440
5,440
5,440
5,4405,4405,4405,4405,4405,4405,4405,4406,0006,0006,0006,0006,0002,500002,500
       Accounts payable 
7,478
0
0
7,796
8,171
9,806
11,704
8,917
8,154
10,384
23,267
9,459
5,991
4,784
6,658
9,424
10,729
10,7299,4246,6584,7845,9919,45923,26710,3848,1548,91711,7049,8068,1717,796007,478
       Other Current Liabilities 
18,743
0
0
209,481
38,546
30,271
37,579
32,720
65,690
67,158
74,077
89,101
89,356
105,573
52,884
53,147
60,526
60,52653,14752,884105,57389,35689,10174,07767,15865,69032,72037,57930,27138,546209,4810018,743
   > Long-term Liabilities 
403,607
0
0
421,667
985,167
976,760
1,103,333
1,326,715
1,279,138
1,302,253
1,285,477
1,291,575
1,266,928
1,289,854
1,291,880
1,297,019
610,098
610,0981,297,0191,291,8801,289,8541,266,9281,291,5751,285,4771,302,2531,279,1381,326,7151,103,333976,760985,167421,66700403,607
       Long term Debt Total 
0
0
0
0
0
0
526,583
525,584
524,591
524,499
523,655
522,824
0
521,161
520,336
0
0
00520,336521,1610522,824523,655524,499524,591525,584526,583000000
       Long term Debt 
334,783
0
0
349,204
528,614
527,593
526,583
525,584
524,591
524,499
523,655
522,824
521,997
521,161
520,336
519,520
518,707
518,707519,520520,336521,161521,997522,824523,655524,499524,591525,584526,583527,593528,614349,20400334,783
       Capital Lease Obligations 
52,919
0
0
56,440
56,167
55,924
55,626
55,324
3,722
0
4,311
5,833
57,825
89,667
91,493
89,719
86,820
86,82089,71991,49389,66757,8255,8334,31103,72255,32455,62655,92456,16756,4400052,919
       Other Liabilities 
15,905
0
0
0
0
393,243
521,124
745,807
713,641
711,232
711,232
724,961
693,375
0
687,529
0
0
00687,5290693,375724,961711,232711,232713,641745,807521,124393,243000015,905
       Long-term Liabilities Other 
1,208
0
0
2,601
2,231
2,310
1,057
745,807
754,547
777,754
761,822
768,751
17,419
760,013
763,032
14,578
2,394
2,39414,578763,032760,01317,419768,751761,822777,754754,547745,8071,0572,3102,2312,601001,208
       Deferred Long Term Liability 
0
0
0
0
0
8,571
0
0
2,700
2,800
0
2,400
2,200
8,680
8,512
0
0
008,5128,6802,2002,40002,8002,700008,57100000
> Total Stockholder Equity
141,396
144,627
0
-52,574
88,511
112,611
193,921
302,637
315,499
382,559
456,588
503,761
545,218
521,517
520,571
519,294
416,753
416,753519,294520,571521,517545,218503,761456,588382,559315,499302,637193,921112,61188,511-52,5740144,627141,396
   Common Stock
183,910
0
0
0
2,576
2,576
2,576
2,576
2,552
2,552
2,552
2,552
2,554
2,509
2,510
2,510
2,513
2,5132,5102,5102,5092,5542,5522,5522,5522,5522,5762,5762,5762,576000183,910
   Retained Earnings 
-42,381
0
0
-52,410
854
24,101
73,176
127,450
184,561
251,423
322,663
367,132
404,766
404,699
398,158
391,696
285,737
285,737391,696398,158404,699404,766367,132322,663251,423184,561127,45073,17624,101854-52,41000-42,381
   Accumulated Other Comprehensive Income 0000000000-39-42-44-16400-133
   Capital Surplus 
0
0
0
0
0
85,976
118,208
172,611
128,386
128,584
131,373
134,077
0
114,309
119,903
0
0
00119,903114,3090134,077131,373128,584128,386172,611118,20885,97600000
   Treasury Stock00000000000000000



Balance Sheet

Currency in USD. All numbers in thousands.




Cash Flow

Currency in USD. All numbers in thousands.




Income Statement

Currency in USD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue288,945
Cost of Revenue-151,343
Gross Profit137,602137,602
 
Operating Income (+$)
Gross Profit137,602
Operating Expense-141,799
Operating Income-4,197-4,197
 
Operating Expense (+$)
Research Development17,280
Selling General Administrative150,115
Selling And Marketing Expenses0
Operating Expense141,799167,395
 
Net Interest Income (+$)
Interest Income22,606
Interest Expense-45,892
Other Finance Cost-5,220
Net Interest Income-18,066
 
Pretax Income (+$)
Operating Income-4,197
Net Interest Income-18,066
Other Non-Operating Income Expenses0
Income Before Tax (EBT)617,736-626,130
EBIT - interestExpense = -50,089
637,082
-73,137
Interest Expense45,892
Earnings Before Interest and Taxes (EBIT)-4,197663,628
Earnings Before Interest and Taxes (EBITDA)44,584
 
After tax Income (+$)
Income Before Tax617,736
Tax Provision--1,610
Net Income From Continuing Ops59,036619,346
Net Income-119,029
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses293,142
Total Other Income/Expenses Net621,93318,066
 

Technical Analysis of Maravai
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Maravai. The general trend of Maravai is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Maravai's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Maravai Lifesciences Holdings Inc.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 7.79 < 8.84 < 8.87.

The bearish price targets are: 7.205 > 7.19 > 7.18.

Tweet this
Maravai Lifesciences Holdings Inc Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Maravai Lifesciences Holdings Inc. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 > MA 100: The MA 20 is higher than the MA 100. +1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending up: The MA 50 is trending up. +1
  • Close > MA 50: The price is above the MA 50. +1
  • MA 50 > MA 100: The MA 50 is higher than the MA 100. +1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close > MA 100: The price is above the MA 100. +1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Maravai Lifesciences Holdings Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Maravai Lifesciences Holdings Inc. The current macd is -0.06859665.

The long score for the Moving Average Convergence/Divergence (MACD) is 1/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -2/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Maravai price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Maravai. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Maravai price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending up: The MACD line is trending up. This indicates that the short-term moving average is rising faster than the long-term moving average, suggesting positive momentum in the market. This signals that buyers are becoming more active and confident, leading to potential price increases as traders anticipate further gains and are willing to buy at higher prices. +1
Maravai Lifesciences Holdings Inc Daily Moving Average Convergence/Divergence (MACD) ChartMaravai Lifesciences Holdings Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Maravai Lifesciences Holdings Inc. The current adx is 15.50.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Maravai shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Maravai Lifesciences Holdings Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Maravai Lifesciences Holdings Inc. The current sar is 7.19.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Maravai Lifesciences Holdings Inc Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Maravai Lifesciences Holdings Inc. The current rsi is 49.80. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is -2/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
  • Trending up: The RSI is trending up. +1
Maravai Lifesciences Holdings Inc Daily Relative Strength Index (RSI) ChartMaravai Lifesciences Holdings Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Maravai Lifesciences Holdings Inc. The current phase is Correction in bull market.

The long score for the Stochastic Oscillator is 3/6.
The longshort score for the Stochastic Oscillator is 2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line > STOCH %D line: The STOCH %K line is above the STOCH %D line, which indicates a bullish signal in the market. This means that the positive momentum is currently stronger than the average momentum, suggesting that buyers are more active than sellers, and there's a higher probability of the Maravai price going up in the near term. +2
  • Trending up: The STOCH %K is trending up. +1
Maravai Lifesciences Holdings Inc Daily Stochastic Oscillator ChartMaravai Lifesciences Holdings Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Maravai Lifesciences Holdings Inc. The current cci is -35.13072657.

Maravai Lifesciences Holdings Inc Daily Commodity Channel Index (CCI) ChartMaravai Lifesciences Holdings Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Maravai Lifesciences Holdings Inc. The current cmo is -0.28188154.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Maravai Lifesciences Holdings Inc Daily Chande Momentum Oscillator (CMO) ChartMaravai Lifesciences Holdings Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Maravai Lifesciences Holdings Inc. The current willr is -57.14285714.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Maravai is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Maravai Lifesciences Holdings Inc Daily Williams %R ChartMaravai Lifesciences Holdings Inc Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Maravai Lifesciences Holdings Inc.

Maravai Lifesciences Holdings Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Maravai Lifesciences Holdings Inc. The current atr is 0.4296129.

Maravai Lifesciences Holdings Inc Daily Average True Range (ATR) ChartMaravai Lifesciences Holdings Inc Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Maravai Lifesciences Holdings Inc. The current obv is -6,757,545.

Maravai Lifesciences Holdings Inc Daily On-Balance Volume (OBV) ChartMaravai Lifesciences Holdings Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Maravai Lifesciences Holdings Inc. The current mfi is 47.31.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -1/(-2 +2).

  • MFI < 50: -1
Maravai Lifesciences Holdings Inc Daily Money Flow Index (MFI) ChartMaravai Lifesciences Holdings Inc Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Maravai Lifesciences Holdings Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-07STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-27STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-03ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-01-16CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-24CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-01-26STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-09SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-12DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-02-13DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-15DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-22SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-02-23MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-02-28RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2024-03-08STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-14WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-18MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-20WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-22CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-25STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-27STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-01STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-03STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-04STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-05SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-15CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-17DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-04-22STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-25STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.

6.3. Candlestick Patterns

Maravai Lifesciences Holdings Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Maravai Lifesciences Holdings Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5049.799
Ma 20Greater thanMa 508.017
Ma 50Greater thanMa 1007.767
Ma 100Greater thanMa 2006.907
OpenGreater thanClose7.760
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Maravai with someone you think should read this too:
  • Are you bullish or bearish on Maravai? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Maravai? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Maravai Lifesciences Holdings Inc

I send you an email if I find something interesting about Maravai Lifesciences Holdings Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Maravai Lifesciences Holdings Inc.

Receive notifications about Maravai Lifesciences Holdings Inc in your mailbox!